Cosmos Health Quote - COSM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.7021

Bid

0.702

Offer

0.7021

Volume

51,885

0.701 Day's Range 0.7333

0.4677 52 Week Range 1.65

Market Cap

12.521M

Previous Close

0.7196

Open

0.72

Last Trade

100

0.7021

Last Trade Time

05:32:11

Financial Volume

US$ 37,061

VWAP

0.714282

Average Volume (3m)

517,862

Shares Outstanding

17,834,023

Dividend Yield

PE Ratio

-0.48

Earnings Per Share (EPS)

-1.45

Revenue

53.38M

Net Profit

-25.78M

Cosmos Holdings Inc is engaged in the research, development, and commercialization of pharmaceutical products and medicines across the European Union member states. It offers over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Co... Cosmos Holdings Inc is engaged in the research, development, and commercialization of pharmaceutical products and medicines across the European Union member states. It offers over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, and wholesalers and retail healthcare providers. Show more

Sector

Drugs And Proprietary-whsl

Industry

Drugs And Proprietary-whsl

Website

www.cosmoshold.com

Headquarters

Sparks, Nevada, USA

Founded

Cosmos Health Inc is listed in the Drugs And Proprietary-whsl sector of the NASDAQ with ticker COSM. The last closing price for Cosmos Health was US$0.72. Over the last year, Cosmos Health shares have traded in a share price range of US$ 0.4677 to US$ 1.65.

Cosmos Health currently has 17,834,023 shares in issue. The market capitalisation of Cosmos Health is US$12.83 million. Cosmos Health has a price to earnings ratio (PE ratio) of -0.48.

Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.

Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc. PR Newswire LONDON...

Form EFFECT - Notice of Effectiveness

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0307	-4.18941048035	0.7328	0.7933	0.701	254799	0.7397131	CS
4	-0.0878	-11.1153310546	0.7899	0.8749	0.701	150989	0.75876175	CS
12	-0.3479	-33.1333333333	1.05	1.58	0.701	517862	1.1398693	CS
26	0.0396	5.97735849057	0.6625	1.58	0.6	1275431	1.067883	CS
52	-0.4479	-38.947826087	1.15	1.65	0.4677	777626	1.05020305	CS
156	-86.7979	-99.1976	87.5	98	0.4677	7277141	9.16261344	CS
260	-86.7979	-99.1976	87.5	98	0.4677	7277141	9.16261344	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SPPLSIMPPLE Ltd	US$ 0.8493 (165.41%)	286.14M
NUWENewellis Inc	US$ 2.69 (97.79%)	89.23M
STAFStaffing 360 Solutions Inc	US$ 2.782 (63.65%)	48.87M
OMICSingular Genomics Systems Inc	US$ 21.51 (59.81%)	263.09k
ADNAdvent Technologies Holdings Inc	US$ 3.0274 (59.34%)	62.65M
FIACFocus Impact Acquisition Corporation	US$ 1.00 (-88.74%)	172
SSPEW Scripps Company	US$ 2.2471 (-36.16%)	2.68M
INVZWInnoviz Technologies Ltd	US$ 0.0642 (-33.13%)	1.98k
GCTKGlucoTrack Inc	US$ 1.21 (-30.46%)	49.39k
ELABElevai Labs Inc	US$ 0.0202 (-30.10%)	208.8M
SPPLSIMPPLE Ltd	US$ 0.8493 (165.41%)	286.14M
ELABElevai Labs Inc	US$ 0.0202 (-30.10%)	208.8M
SQQQProShares UltraPro Short QQQ	US$ 7.445 (0.07%)	126.61M
NVDANVIDIA Corporation	US$ 137.9101 (1.85%)	123.9M
NUWENewellis Inc	US$ 2.69 (97.79%)	89.23M